SRC Homology 2 Domain Binding Sites in Insulin, IGF-1 and FGF receptor mediated signaling networks reveal an extensive potential interactome

Cell Communication and Signaling

Volumn 10, Issue , 2012, Pages

  Liu, Bernard A ^a,c   Engelmann, Brett W ^a,b   Jablonowski, Karl ^a,d   Higginbotham, Katherine ^a   Stergachis, Andrew B ^a   Nash, Piers D ^a,b  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR; INSULIN; PEPTIDE; PHOSPHOTYROSINE; PROTEIN SH2; SOMATOMEDIN C;

ARTICLE; BINDING SITE; CONTROLLED STUDY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 84870521139     PISSN: None     EISSN: 1478811X     Source Type: Journal    
DOI: 10.1186/1478-811X-10-27     Document Type: Article

References (124)

1. Receptor protein-tyrosine kinases and their signal transduction pathways. van der Geer P, Hunter T, Lindberg RA, Annu Rev Cell Biol 1994 10 251 337 10.1146/annurev.cb.10.110194.001343 7888178 (Pubitemid 24372822)
2. Signalling by receptor tyrosine kinases. Fantl WJ, Johnson DE, Williams LT, Annu Rev Biochem 1993 62 453 481 10.1146/annurev.bi.62.070193.002321 7688944 (Pubitemid 23237878)
3. Cell signaling by receptor tyrosine kinases. Lemmon MA, Schlessinger J, Cell 2010 141 1117 1134 10.1016/j.cell.2010.06.011 20602996
4. Phosphotyrosine-binding domains in signal transduction. Yaffe MB, Nat Rev Mol Cell Biol 2002 3 177 186 10.1038/nrm759 11994738
5. Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Pawson T, Cell 2004 116 191 203 10.1016/S0092-8674(03)01077-8 14744431 (Pubitemid 38167312)
6. SH2 domains, interaction modules and cellular wiring. Pawson T, Gish GD, Nash P, Trends Cell Biol 2001 11 504 511 10.1016/S0962-8924(01)02154-7 11719057 (Pubitemid 33079144)
7. Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins. Matsuda M, Mayer BJ, Fukui Y, Hanafusa H, Science 1990 248 1537 1539 10.1126/science.1694307 1694307
8. The tyrosine phosphorylated carboxyterminus of the EGF receptor is a binding site for GAP and PLC-gamma. Margolis B, Li N, Koch A, Mohammadi M, Hurwitz DR, Zilberstein A, Ullrich A, Pawson T, Schlessinger J, EMBO J 1990 9 4375 4380 2176151 (Pubitemid 120025994)
9. Src homology region 2 domains direct protein-protein interactions in signal transduction. Moran MF, Koch CA, Anderson D, Ellis C, England L, Martin GS, Pawson T, Proc Natl Acad Sci USA 1990 87 8622 8626 10.1073/pnas.87.21.8622 2236073
10. SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Koch CA, Anderson D, Moran MF, Ellis C, Pawson T, Science 1991 252 668 674 10.1126/science.1708916 1708916 (Pubitemid 21916987)
11. The language of SH2 domain interactions defines phosphotyrosine-mediated signal transduction. Liu BA, Engelmann BW, Nash PD, FEBS Lett 2012 586 2597 2605 10.1016/j.febslet.2012.04.054 22569091
12. Assembly of cell regulatory systems through protein interaction domains. Pawson T, Nash P, Science 2003 300 445 452 10.1126/science.1083653 12702867 (Pubitemid 36444318)
13. Protein-protein interactions define specificity in signal transduction. Pawson T, Nash P, Genes Dev 2000 14 1027 1047 10809663 (Pubitemid 30324418)
14. The Human and Mouse Complement of SH2 Domain Proteins-Establishing the Boundaries of Phosphotyrosine Signaling. Liu BA, Jablonowski K, Raina M, Arce M, Pawson T, Nash PD, Mol Cell 2006 22 851 868 10.1016/j.molcel.2006.06.001 16793553
15. The SH2 domain-containing proteins in 21 extant species establish the provenance and scope of phosphotyrosine signaling in Eukaryotes. Liu BA, Shah E, Jablonowski K, Stergachis A, Engelmann BW, Nash PD, Sci Signal 2011 4 a83 10.1126/scisignal.2002105 22155787
16. Genome wide analysis of pathogenic SH2 domain mutations. Lappalainen I, Thusberg J, Shen B, Vihinen M, Proteins 2008 72 779 792 10.1002/prot.21970 18260110 (Pubitemid 351928530)
17. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase. Bradshaw JM, Mitaxov V, Waksman G, J Mol Biol 1999 293 971 985 10.1006/jmbi.1999.3190 10543978 (Pubitemid 29527677)
18. Molecular recognition by SH2 domains. Bradshaw JM, Waksman G, Adv Protein Chem 2002 61 161 210 12461824 (Pubitemid 35303457)
19. SH2 domains recognize specific phosphopeptide sequences. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, et al. Cell 1993 72 767 778 10.1016/0092-8674(93) 90404-E 7680959 (Pubitemid 23093884)
20. Defining the specificity space of the human SRC homology 2 domain. Huang H, Li L, Wu C, Schibli D, Colwill K, Ma S, Li C, Roy P, Ho K, Songyang Z, et al. Mol Cell Proteomics 2008 7 768 784 17956856 (Pubitemid 351597486)
21. Scansite 2.0: Proteome-wide prediction of cell signaling interactions using short sequence motifs. Obenauer JC, Cantley LC, Yaffe MB, Nucleic Acids Res 2003 31 3635 3641 10.1093/nar/gkg584 12824383 (Pubitemid 37442212)
22. SH2 domains recognize contextual peptide sequence information to determine selectivity. Liu BA, Jablonowski K, Shah EE, Engelmann BW, Jones RB, Nash PD, Mol Cell Proteomics 2010 9 2391 2404 10.1074/mcp.M110.001586 20627867
23. High-throughput phosphotyrosine profiling using SH2 domains. Machida K, Thompson CM, Dierck K, Jablonowski K, Karkkainen S, Liu B, Zhang H, Nash PD, Newman DK, Nollau P, et al. Mol Cell 2007 26 899 915 10.1016/j.molcel.2007.05. 031 17588523 (Pubitemid 46929095)
24. Quantitative multiplexed profiling of cellular signaling networks using phosphotyrosine-specific DNA-tagged SH2 domains. Dierck K, Machida K, Voigt A, Thimm J, Horstmann M, Fiedler W, Mayer BJ, Nollau P, Nat Methods 2006 3 737 744 10.1038/nmeth917 16929320 (Pubitemid 44275743)
25. The SH2 domain: versatile signaling module and pharmaceutical target. Machida K, Mayer BJ, Biochim Biophys Acta 2005 1747 1 25 10.1016/j.bbapap.2004. 10.005 15680235 (Pubitemid 40170450)
26. Profiling the global tyrosine phosphorylation state. Machida K, Mayer BJ, Nollau P, Mol Cell Proteomics 2003 2 215 233 12754303
27. Characterizing tyrosine phosphorylation signaling in lung cancer using SH2 profiling. Machida K, Eschrich S, Li J, Bai Y, Koomen J, Mayer BJ, Haura EB, PLoS One 2010 5 13470 10.1371/journal.pone.0013470 20976048
28. Probing the phosphopeptide specificities of protein tyrosine phosphatases, SH2 and PTB domains with combinatorial library methods. Vetter SW, Zhang ZY, Curr Protein Pept Sci 2002 3 365 397 10.2174/1389203023380594 12370002 (Pubitemid 34778182)
29. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Songyang Z, Shoelson SE, McGlade J, Olivier P, Pawson T, Bustelo XR, Barbacid M, Sabe H, Hanafusa H, Yi T, et al. Mol Cell Biol 1994 14 2777 2785 10.1128/MCB.14.4.2777 7511210
30. An oriented peptide array library (OPAL) strategy to study protein-protein interactions. Rodriguez M, Li SS, Harper JW, Songyang Z, J Biol Chem 2004 279 8802 8807 10.1074/jbc.M311886200 14679191 (Pubitemid 38295938)
31. Identification of natural ligands for SH2 domains from a phage display cDNA library. Cochrane D, Webster C, Masih G, McCafferty J, J Mol Biol 2000 297 89 97 10.1006/jmbi.2000.3561 10704309
32. Combining peptide recognition specificity and context information for the prediction of the 14-3-3-mediated interactome in S. cerevisiae and H. sapiens. Panni S, Montecchi-Palazzi L, Kiemer L, Cabibbo A, Paoluzi S, Santonico E, Landgraf C, Volkmer-Engert R, Bachi A, Castagnoli L, Cesareni G, Proteomics 2011 11 128 143 10.1002/pmic.201000030 21182200
33. A tissue-specific atlas of mouse protein phosphorylation and expression. Huttlin EL, Jedrychowski MP, Elias JE, Goswami T, Rad R, Beausoleil SA, Villen J, Haas W, Sowa ME, Gygi SP, Cell 2010 143 1174 1189 10.1016/j.cell.2010.12.001 21183079
34. The complexity of cell signaling and the need for a new mechanics. Hlavacek WS, Faeder JR, Sci Signal 2009 2 e46 10.1126/scisignal.281pe46 19638613
35. Scaffold-mediated nucleation of protein signaling complexes: Elementary principles. Yang J, Hlavacek WS, Math Biosci 2011 232 164 173 10.1016/j.mbs.2011.06.003 21683720
36. Towards a knowledge-based Human Protein Atlas. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, et al. Nat Biotechnol 2010 28 1248 1250 10.1038/nbt1210-1248 21139605
37. SPOT synthesis: reliability of array-based measurement of peptide binding affinity. Weiser AA, Or-Guil M, Tapia V, Leichsenring A, Schuchhardt J, Frommel C, Volkmer-Engert R, Anal Biochem 2005 342 300 311 10.1016/j.ab.2005.04.033 15950918 (Pubitemid 40884580)
38. Studying protein-protein interactions using peptide arrays. Katz C, Levy-Beladev L, Rotem-Bamberger S, Rito T, Rudiger SG, Friedler A, Chem Soc Rev 2011 40 2131 2145 10.1039/c0cs00029a 21243154
39. Spot synthesis: observations and optimizations. Kramer A, Reineke U, Dong L, Hoffmann B, Hoffmuller U, Winkler D, Volkmer-Engert R, Schneider-Mergener J, J Pept Res 1999 54 319 327 10.1034/j.1399-3011.1999.00108.x 10532237 (Pubitemid 29459731)
40. Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nash P, Tang X, Orlicky S, Chen Q, Gertler FB, Mendenhall MD, Sicheri F, Pawson T, Tyers M, Nature 2001 414 514 521 10.1038/35107009 11734846 (Pubitemid 33131529)
41. The SPOT-synthesis technique. Synthetic peptide arrays on membrane supports - principles and applications. Frank R, J Immunol Methods 2002 267 13 26 10.1016/S0022-1759(02)00137-0 12135797 (Pubitemid 34804809)
42. SPOT synthesis. Epitope analysis with arrays of synthetic peptides prepared on cellulose membranes. Frank R, Overwin H, Methods Mol Biol 1996 66 149 169 8959713
43. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A. Li SC, Gish G, Yang D, Coffey AJ, Forman-Kay JD, Ernberg I, Kay LE, Pawson T, Curr Biol 1999 9 1355 1362 10.1016/S0960-9822(00) 80080-9 10607564
44. A study to assess the cross-reactivity of cellulose membrane-bound peptides with detection systems: an analysis at the amino acid level. Mahrenholz CC, Tapia V, Stigler RD, Volkmer R, J Pept Sci 2010 16 297 302 20474041
45. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85. Myers MG Jr, Backer JM, Sun XJ, Shoelson S, Hu P, Schlessinger J, Yoakim M, Schaffhausen B, White MF, Proc Natl Acad Sci USA 1992 89 10350 10354 10.1073/pnas.89.21.10350 1332046
46. The Fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation. Sun XJ, Pons S, Asano T, Myers MG Jr, Glasheen E, White MF, J Biol Chem 1996 271 10583 10587 10.1074/jbc.271.18.10583 8631859 (Pubitemid 26149894)
47. YMXM motifs and signaling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites. Myers MG Jr, Zhang Y, Aldaz GA, Grammer T, Glasheen EM, Yenush L, Wang LM, Sun XJ, Blenis J, Pierce JH, White MF, Mol Cell Biol 1996 16 4147 4155 8754813 (Pubitemid 26251214)
48. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Sadowski I, Stone JC, Pawson T, Mol Cell Biol 1986 6 4396 4408 3025655 (Pubitemid 17217381)
49. UniHI: an entry gate to the human protein interactome. Chaurasia G, Iqbal Y, Hanig C, Herzel H, Wanker EE, Futschik ME, Nucleic Acids Res 2007 35 590 D594 10.1093/nar/gkl817 17158159 (Pubitemid 46056275)
50. MINT: the Molecular INTeraction database. Chatr-aryamontri A, Ceol A, Palazzi LM, Nardelli G, Schneider MV, Castagnoli L, Cesareni G, Nucleic Acids Res 2007 35 572 D574 10.1093/nar/gkl950 17135203 (Pubitemid 46056272)
51. BIND: the Biomolecular Interaction Network Database. Bader GD, Betel D, Hogue CW, Nucleic Acids Res 2003 31 248 250 10.1093/nar/gkg056 12519993 (Pubitemid 36150376)
52. Human protein reference database-2006 update. Mishra GR, Suresh M, Kumaran K, Kannabiran N, Suresh S, Bala P, Shivakumar K, Anuradha N, Reddy R, Raghavan TM, et al. Nucleic Acids Res 2006 34 411 D414 10.1093/nar/gkj141 16381900
53. The Database of Interacting Proteins: 2004 update. Salwinski L, Miller CS, Smith AJ, Pettit FK, Bowie JU, Eisenberg D, Nucleic Acids Res 2004 32 449 D451 10.1093/nar/gkh086 14681454
54. High-throughput analysis of peptide binding modules. Liu BA, Engelmann BW, Nash PD, Proteomics 2012 12 1527 1546 10.1002/pmic.201100599 22610655
55. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mohammadi M, Honegger AM, Rotin D, Fischer R, Bellot F, Li W, Dionne CA, Jaye M, Rubinstein M, Schlessinger J, Mol Cell Biol 1991 11 5068 5078 1656221 (Pubitemid 21895268)
56. Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis. Peters KG, Marie J, Wilson E, Ives HE, Escobedo J, Del Rosario M, Mirda D, Williams LT, Nature 1992 358 678 681 10.1038/358678a0 1379697
57. A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R. Kaushansky A, Gordus A, Chang B, Rush J, MacBeath G, Mol Biosyst 2008 4 643 653 10.1039/b801018h 18493663 (Pubitemid 351706308)
58. A quantitative protein interaction network for the ErbB receptors using protein microarrays. Jones RB, Gordus A, Krall JA, MacBeath G, Nature 2006 439 168 174 10.1038/nature04177 16273093 (Pubitemid 43083134)
59. Application of Celluspots peptide arrays for the analysis of the binding specificity of epigenetic reading domains to modified histone tails. Bock I, Kudithipudi S, Tamas R, Kungulovski G, Dhayalan A, Jeltsch A, BMC Biochem 2011 12 48 10.1186/1471-2091-12-48 21884582
60. PDZ domain binding selectivity is optimized across the mouse proteome. Stiffler MA, Chen JR, Grantcharova VP, Lei Y, Fuchs D, Allen JE, Zaslavskaia LA, MacBeath G, Science 2007 317 364 369 10.1126/science.1144592 17641200 (Pubitemid 47106375)
61. Quantifying protein-protein interactions in high throughput using protein domain microarrays. Kaushansky A, Allen JE, Gordus A, Stiffler MA, Karp ES, Chang BH, MacBeath G, Nat Protoc 2010 5 773 790 20360771
62. A systematic family-wide investigation reveals that 30% of mammalian PDZ domains engage in PDZ-PDZ interactions. Chang BH, Gujral TS, Karp ES, BuKhalid R, Grantcharova VP, MacBeath G, Chem Biol 2011 18 1143 1152 10.1016/j.chembiol. 2011.06.013 21944753
63. The hematopoietic-specific adaptor protein gads functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors. Liu SK, Fang N, Koretzky GA, McGlade CJ, Curr Biol 1999 9 67 75 10.1016/S0960-9822(99)80017-7 10021361 (Pubitemid 29083530)
64. Grap is a novel SH3-SH2-SH3 adaptor protein that couples tyrosine kinases to the Ras pathway. Feng GS, Ouyang YB, Hu DP, Shi ZQ, Gentz R, Ni J, J Biol Chem 1996 271 12129 12132 10.1074/jbc.271.21.12129 8647802 (Pubitemid 26160867)
65. PhosphoSite: A bioinformatics resource dedicated to physiological protein phosphorylation. Hornbeck PV, Chabra I, Kornhauser JM, Skrzypek E, Zhang B, Proteomics 2004 4 1551 1561 10.1002/pmic.200300772 15174125 (Pubitemid 38738314)
66. Identification of a molecular recognition role for the activation loop phosphotyrosine of the SRC tyrosine kinase. Videlock EJ, Chung VK, Hall JM, Hines J, Agapakis CM, Austin DJ, J Am Chem Soc 2005 127 1600 1601 10.1021/ja047957c 15700969 (Pubitemid 40229121)
67. Packing at the protein-water interface. Gerstein M, Chothia C, Proc Natl Acad Sci USA 1996 93 10167 10172 10.1073/pnas.93.19.10167 8816770 (Pubitemid 26314593)
68. The packing density in proteins: standard radii and volumes. Tsai J, Taylor R, Chothia C, Gerstein M, J Mol Biol 1999 290 253 266 10.1006/jmbi.1999.2829 10388571 (Pubitemid 29308589)
69. WebLogo: a sequence logo generator. Crooks GE, Hon G, Chandonia JM, Brenner SE, Genome Res 2004 14 1188 1190 10.1101/gr.849004 15173120 (Pubitemid 38811555)
70. Evolution of SH2 domains and phosphotyrosine signaling networks. Liu BA, Nash PD, Philos Trans R Soc Lond B Biol Sci 2012 367 2555 2572
71. Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor. Bisson N, James DA, Ivosev G, Tate SA, Bonner R, Taylor L, Pawson T, Nat Biotechnol 2011 29 653 658 10.1038/nbt.1905 21706016
72. The proliferating role of insulin and insulin-like growth factors in cancer. Gallagher EJ, LeRoith D, Trends Endocrinol Metab 2010 21 610 618 10.1016/j.tem.2010.06.007 20663687
73. Signalling by insulin and IGF receptors: supporting acts and new players. Siddle K, J Mol Endocrinol 2011 47 1 R10 10.1530/JME-11-0022 21498522
74. Targeting the insulin-like growth factor network in cancer therapy. Heidegger I, Pircher A, Klocker H, Massoner P, Cancer Biol Ther 2011 11 701 707 10.4161/cbt.11.8.14689 21311212
75. Insulin resistance, metabolic stress, and atherosclerosis. Pansuria M, Xi H, Li L, Yang XF, Wang H, Front Biosci (Schol Ed) 2012 4 916 931
76. Insulin resistance in the nervous system. Kim B, Feldman EL, Trends Endocrinol Metab 2012 23 133 141 10.1016/j.tem.2011.12.004 22245457
77. Calorimetric examination of high-affinity Src SH2 domain-tyrosyl phosphopeptide binding: dissection of the phosphopeptide sequence specificity and coupling energetics. Bradshaw JM, Waksman G, Biochemistry 1999 38 5147 5154 10.1021/bi982974y 10213620 (Pubitemid 29196364)
78. Independent binding of peptide ligands to the SH2 and SH3 domains of Grb2. Lemmon MA, Ladbury JE, Mandiyan V, Zhou M, Schlessinger J, J Biol Chem 1994 269 31653 31658 7527391 (Pubitemid 24379530)
79. Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding. Piccione E, Case RD, Domchek SM, Hu P, Chaudhuri M, Backer JM, Schlessinger J, Shoelson SE, Biochemistry 1993 32 3197 3202 10.1021/bi00064a001 8384875 (Pubitemid 23126884)
80. Protein-tyrosine kinases. Hunter T, Cooper JA, Annu Rev Biochem 1985 54 897 930 10.1146/annurev.bi.54.070185.004341 2992362 (Pubitemid 15073667)
81. Human protein reference database as a discovery resource for proteomics. Peri S, Navarro JD, Kristiansen TZ, Amanchy R, Surendranath V, Muthusamy B, Gandhi TK, Chandrika KN, Deshpande N, Suresh S, et al. Nucleic Acids Res 2004 32 497 D501 10.1093/nar/gkh070 14681466
82. Systematic discovery of in vivo phosphorylation networks. Linding R, Jensen LJ, Ostheimer GJ, van Vugt MA, Jorgensen C, Miron IM, Diella F, Colwill K, Taylor L, Elder K, et al. Cell 2007 129 1415 1426 10.1016/j.cell.2007.05.052 17570479 (Pubitemid 46962092)
83. Optimization of specificity in a cellular protein interaction network by negative selection. Zarrinpar A, Park SH, Lim WA, Nature 2003 426 676 680 10.1038/nature02178 14668868 (Pubitemid 38009377)
84. A novel viral oncogene with structural similarity to phospholipase C. Mayer BJ, Hamaguchi M, Hanafusa H, Nature 1988 332 272 275 10.1038/332272a0 2450282 (Pubitemid 18076660)
85. PHYLIP - Phylogeny Inference Package (Version 3.2). Felsenstein J, Cladistics 1989 5 164 166
86. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Tamura K, Dudley J, Nei M, Kumar S, Mol Biol Evol 2007 24 1596 1599 10.1093/molbev/msm092 17488738 (Pubitemid 47236692)
87. Subsets of the major tyrosine phosphorylation sites in Crk-associated substrate (CAS) are sufficient to promote cell migration. Shin NY, Dise RS, Schneider-Mergener J, Ritchie MD, Kilkenny DM, Hanks SK, J Biol Chem 2004 279 38331 38337 10.1074/jbc.M404675200 15247284 (Pubitemid 39295981)
88. Tyrosine-phosphorylated Cbl binds to Crk after T cell activation. Sawasdikosol S, Chang JH, Pratt JC, Wolf G, Shoelson SE, Burakoff SJ, J Immunol 1996 157 110 116 8683103 (Pubitemid 26190537)
89. The proto-oncogene p120(Cbl) is a downstream substrate of the Hck protein-tyrosine kinase. Howlett CJ, Bisson SA, Resek ME, Tigley AW, Robbins SM, Biochem Biophys Res Commun 1999 257 129 138 10.1006/bbrc.1999.0427 10092522 (Pubitemid 29299059)
90. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. Hunter S, Burton EA, Wu SC, Anderson SM, J Biol Chem 1999 274 2097 2106 10.1074/jbc.274.4.2097 9890970 (Pubitemid 29061362)
91. The phosphotyrosine peptide binding specificity of Nck1 and Nck2 Src homology 2 domains. Frese S, Schubert WD, Findeis AC, Marquardt T, Roske YS, Stradal TE, Heinz DW, J Biol Chem 2006 281 18236 18245 10.1074/jbc.M512917200 16636066 (Pubitemid 44035624)
92. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. Skolnik EY, Lee CH, Batzer A, Vicentini LM, Zhou M, Daly R, Myers MJ Jr, Backer JM, Ullrich A, White MF, et al. EMBO J 1993 12 1929 1936 8491186 (Pubitemid 23157709)
93. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG, et al. Nature 1992 360 689 692 10.1038/360689a0 1465135 (Pubitemid 23007687)
94. Rapid identification of phosphopeptide ligands for SH2 domains. Screening of peptide libraries by fluorescence-activated bead sorting. Muller K, Gombert FO, Manning U, Grossmuller F, Graff P, Zaegel H, Zuber JF, Freuler F, Tschopp C, Baumann G, J Biol Chem 1996 271 16500 16505 10.1074/jbc.271.28.16500 8663178 (Pubitemid 26239001)
95. Tandem SH2 domains confer high specificity in tyrosine kinase signaling. Ottinger EA, Botfield MC, Shoelson SE, J Biol Chem 1998 273 729 735 10.1074/jbc.273.2.729 9422724 (Pubitemid 28049159)
96. Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-gamma 1 complexed with a high affinity binding peptide. Pascal SM, Singer AU, Gish G, Yamazaki T, Shoelson SE, Pawson T, Kay LE, Forman-Kay JD, Cell 1994 77 461 472 10.1016/0092-8674(94)90160-0 8181064 (Pubitemid 24145206)
97. NMR dynamics-derived insights into the binding properties of a peptide interacting with an SH2 domain. Finerty PJ Jr, Mittermaier AK, Muhandiram R, Kay LE, Forman-Kay JD, Biochemistry 2005 44 694 703 10.1021/bi048641k 15641795 (Pubitemid 40105500)
98. A repertoire library that allows the selection of synthetic SH2s with altered binding specificities. Malabarba MG, Milia E, Faretta M, Zamponi R, Pelicci PG, Di Fiore PP, Oncogene 2001 20 5186 5194 10.1038/sj.onc.1204654 11526507 (Pubitemid 32844047)
99. Vav family proteins couple to diverse cell surface receptors. Moores SL, Selfors LM, Fredericks J, Breit T, Fujikawa K, Alt FW, Brugge JS, Swat W, Mol Cell Biol 2000 20 6364 6373 10.1128/MCB.20.17.6364-6373.2000 10938113 (Pubitemid 30650223)
100. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells. Morra M, Lu J, Poy F, Martin M, Sayos J, Calpe S, Gullo C, Howie D, Rietdijk S, Thompson A, et al. EMBO J 2001 20 5840 5852 10.1093/emboj/20.21.5840 11689425 (Pubitemid 33049260)
101. Solution structure of the Shc SH2 domain complexed with a tyrosine-phosphorylated peptide from the T-cell receptor. Zhou MM, Meadows RP, Logan TM, Yoon HS, Wade WS, Ravichandran KS, Burakoff SJ, Fesik SW, Proc Natl Acad Sci USA 1995 92 7784 7788 10.1073/pnas.92.17.7784 7544002
102. The protein tyrosine phosphatase SHP-2 negatively regulates ciliary neurotrophic factor induction of gene expression. Symes A, Stahl N, Reeves SA, Farruggella T, Servidei T, Gearan T, Yancopoulos G, Fink JS, Curr Biol 1997 7 697 700 10.1016/S0960-9822(06)00298-3 9285712 (Pubitemid 27408869)
103. From consensus sequence peptide to high affinity ligand, a "library scan" strategy. Yeh RH, Lee TR, Lawrence DS, J Biol Chem 2001 276 12235 12240 10.1074/jbc.M011232200 11278862
104. Functional interactions of HPK1 with adaptor proteins. Boomer JS, Tan TH, J Cell Biochem 2005 95 34 44 10.1002/jcb.20401 15770651 (Pubitemid 41420213)
105. Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3 T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin. Kayali AG, Eichhorn J, Haruta T, Morris AJ, Nelson JG, Vollenweider P, Olefsky JM, Webster NJ, J Biol Chem 1998 273 13808 13818 10.1074/jbc.273.22. 13808 9593725 (Pubitemid 28268431)
106. White MF, Schlessinger J, Skolnik EY: Nck associates with the SH2 domain-docking protein IRS-1 in insulin-stimulated cells. Lee CH, Li W, Nishimura R, Zhou M, Batzer AG, Myers MG Jr, Proc Natl Acad Sci USA 1993 90 11713 11717 10.1073/pnas.90.24.11713 8265614 (Pubitemid 24008709)
107. SH-PTP2/Syp SH2 domain binding specificity is defined by direct interactions with platelet-derived growth factor beta-receptor, epidermal growth factor receptor, and insulin receptor substrate-1-derived phosphopeptides. Case RD, Piccione E, Wolf G, Benett AM, Lechleider RJ, Neel BG, Shoelson SE, J Biol Chem 1994 269 10467 10474 8144631
108. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Sun XJ, Crimmins DL, Myers MG Jr, Miralpeix M, White MF, Mol Cell Biol 1993 13 7418 7428 7504175 (Pubitemid 23354266)
109. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Skolnik EY, Batzer A, Li N, Lee CH, Lowenstein E, Mohammadi M, Margolis B, Schlessinger J, Science 1993 260 1953 1955 10.1126/science.8316835 8316835 (Pubitemid 23258278)
110. The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling. Myers MG Jr, Mendez R, Shi P, Pierce JH, Rhoads R, White MF, J Biol Chem 1998 273 26908 26914 10.1074/jbc.273.41.26908 9756938 (Pubitemid 28471711)
111. IL-13 induces tyrosine phosphorylation of phospholipase C gamma-1 following IRS-2 association in human monocytes: relationship with the inhibitory effect of IL-13 on ROI production. Sozzani P, Hasan L, Seguelas MH, Caput D, Ferrara P, Pipy B, Cambon C, Biochem Biophys Res Commun 1998 244 665 670 10.1006/bbrc.1998.8314 9535722 (Pubitemid 28418125)
112. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice. Patti ME, Sun XJ, Bruening JC, Araki E, Lipes MA, White MF, Kahn CR, J Biol Chem 1995 270 24670 24673 10.1074/jbc.270.42.24670 7559579
113. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells. Cross MJ, Lu L, Magnusson P, Nyqvist D, Holmqvist K, Welsh M, Claesson-Welsh L, Mol Biol Cell 2002 13 2881 2893 10.1091/mbc.E02-02-0103 12181353
114. Interaction of fibroblast growth factor receptor 3 and the adapter protein SH2-B. A role in STAT5 activation. Kong M, Wang CS, Donoghue DJ, J Biol Chem 2002 277 15962 15970 10.1074/jbc.M102777200 11827956 (Pubitemid 34967878)
115. Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1. Vainikka S, Joukov V, Wennstrom S, Bergman M, Pelicci PG, Alitalo K, J Biol Chem 1994 269 18320 18326 7518429 (Pubitemid 24224057)
116. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Kouhara H, Hadari YR, Spivak-Kroizman T, Schilling J, Bar-Sagi D, Lax I, Schlessinger J, Cell 1997 89 693 702 10.1016/S0092-8674(00)80252-4 9182757 (Pubitemid 27516172)
117. Binding of Shp2 tyrosine phosphatase to FRS2 is essential for fibroblast growth factor-induced PC12 cell differentiation. Hadari YR, Kouhara H, Lax I, Schlessinger J, Mol Cell Biol 1998 18 3966 3973 9632781 (Pubitemid 28287920)
118. Intramolecular interaction between phosphorylated tyrosine-783 and the C-terminal Src homology 2 domain activates phospholipase C-gamma1. Poulin B, Sekiya F, Rhee SG, Proc Natl Acad Sci USA 2005 102 4276 4281 10.1073/pnas.0409590102 15764700 (Pubitemid 40397102)
119. Fibronectin-stimulated signaling from a focal adhesion kinase-c-Src complex: involvement of the Grb2, p130cas, and Nck adaptor proteins. Schlaepfer DD, Broome MA, Hunter T, Mol Cell Biol 1997 17 1702 1713 9032297 (Pubitemid 27097399)
120. p130Cas Couples the tyrosine kinase Bmx/Etk with regulation of the actin cytoskeleton and cell migration. Abassi YA, Rehn M, Ekman N, Alitalo K, Vuori K, J Biol Chem 2003 278 35636 35643 10.1074/jbc.M306438200 12832404 (Pubitemid 37102337)
121. Molecular basis for regulation of Src by the docking protein p130Cas. Nasertorabi F, Tars K, Becherer K, Kodandapani R, Liljas L, Vuori K, Ely KR, J Mol Recognit 2006 19 30 38 10.1002/jmr.755 16245368 (Pubitemid 43129784)
122. Tyrosine phosphorylation of p62dok by p210bcr-abl inhibits RasGAP activity. Kashige N, Carpino N, Kobayashi R, Proc Natl Acad Sci USA 2000 97 2093 2098 10.1073/pnas.040547997 10688886 (Pubitemid 30134027)
123. Insulin receptor-mediated p62dok tyrosine phosphorylation at residues 362 and 398 plays distinct roles for binding GTPase-activating protein and Nck and is essential for inhibiting insulin-stimulated activation of Ras and Akt. Wick MJ, Dong LQ, Hu D, Langlais P, Liu F, J Biol Chem 2001 276 42843 42850 10.1074/jbc.M102116200 11551902
124. Independent SH2-binding sites mediate interaction of Dok-related protein with RasGTPase-activating protein and Nck. Lock P, Casagranda F, Dunn AR, J Biol Chem 1999 274 22775 22784 10.1074/jbc.274.32.22775 10428862 (Pubitemid 29379327)